top of page

Our Vision, Mission & Values

Our Vision

Advancing global access to safe, high-quality therapies through pioneering pharmaceutical innovation and accessible healthcare solutions.

Our Mission

Driving end-to-end pharmaceutical excellence from R&D to commercial supply with unmatched manufacturing standards and regulatory compliance.

Core Values

Quality, compliance, and relentless innovation focused on patient-centricity to improve health outcomes globally.

PRECISION API SYNTHESIS • CDMO LEADERSHIP • GXP COMPLIANCE • GLOBAL SOLUTIONS • INNOVATION DRIVEN •

25+

900+

125+

600+

years’ experience

scientists

global clients

discovery & CDMO projects

20

16

6

50

NCEs commercialized

USFDA cGMP facilities

biologics commercialized

manufacturing countries

25+

years’ experience

900+

scientists

125+

global clients

600+

discovery & CDMO projects

20

NCEs commercialized

16

USFDA inspected facilities

6

biologics commercialized

50

manufacturing countries

PRECISION PHARMA SOLUTIONS • 25 YEARS OF EXCELLENCE • GLOBAL REACH • USFDA INSPECTED FACILITIES • CDMO LEADERSHIP

Advanced Pharma Solutions Portfolio

High-Purity API Synthesis

Proprietary synthesis protocols ensuring 99.8%+ purity levels. Engineered for complex small molecule programs requiring rigorous crystalline structure validation.

CRO Analytical Validation

Advanced impurity profiling and GxP-compliant method development. Our analytical suite reduces discovery lead times by 25% for critical therapeutic candidates.

CDMO Commercial Scale-up

Seamless transition from pilot batches to cGMP commercial supply. Optimized PAT strategies reduce time-to-market while maintaining full regulatory compliance.

Sterile API Finishing

High-efficiency aseptic processing and lyophilization services. Our robotic automation ensures 100% sterile integrity for complex parenteral formulations.

Accelerate your therapeutic pipeline with a partner engineered for high-complexity API synthesis and CDMO excellence. Cytonova Labs integrates QbD-driven process development with global GxP regulatory standards to de-risk scale-up and compress commercial timelines.

bottom of page